RENACER - Brain Metastasis Network
@renacerbrainmet.bsky.social
Creating a new paradigm for Brain Metastasis through the development of new personalised cancer therapeutic approaches.
📢 We want to thank @heraldo.es, @elperiodico.com, @infobae.bsky.social, @democrataes.bsky.social, and other media that have highlighted Volume II of Trends in Cancer, ‘The Evolving Landscape of Brain Metastasis’, by Manuel Valiente's group. Thank you for helping science reach beyond the lab!
February 16, 2026 at 11:02 AM
📢 We want to thank @heraldo.es, @elperiodico.com, @infobae.bsky.social, @democrataes.bsky.social, and other media that have highlighted Volume II of Trends in Cancer, ‘The Evolving Landscape of Brain Metastasis’, by Manuel Valiente's group. Thank you for helping science reach beyond the lab!
🤝 Hope is born when committed people come together to improve lives.
Today, on #WorldCancerDay, we prove that this hope is happening. As pointed out by the brain metastasis research group led by Manuel Valiente, we are moving closer to advances that can improve patients' lives.
Today, on #WorldCancerDay, we prove that this hope is happening. As pointed out by the brain metastasis research group led by Manuel Valiente, we are moving closer to advances that can improve patients' lives.
February 4, 2026 at 10:30 AM
🤝 Hope is born when committed people come together to improve lives.
Today, on #WorldCancerDay, we prove that this hope is happening. As pointed out by the brain metastasis research group led by Manuel Valiente, we are moving closer to advances that can improve patients' lives.
Today, on #WorldCancerDay, we prove that this hope is happening. As pointed out by the brain metastasis research group led by Manuel Valiente, we are moving closer to advances that can improve patients' lives.
🧬The CNIO Biobank continues to grow as a key resource for research.
Nearly 56,000 samples from the CNIO Biobank are now part of the world’s largest network of biological resources, available to the entire scientific community.
Nearly 56,000 samples from the CNIO Biobank are now part of the world’s largest network of biological resources, available to the entire scientific community.
January 28, 2026 at 11:01 AM
🧬The CNIO Biobank continues to grow as a key resource for research.
Nearly 56,000 samples from the CNIO Biobank are now part of the world’s largest network of biological resources, available to the entire scientific community.
Nearly 56,000 samples from the CNIO Biobank are now part of the world’s largest network of biological resources, available to the entire scientific community.
📖New article in Trends in Cancer. Volume II of “The evolving landscape of brain metastasis” has been published—a review coordinated by Manuel Valiente, 8 years after Volume I, with contributions from 17 leading figures in the field.
🔗Read full article: doi.org/10.1016/j.tr...
🔗Read full article: doi.org/10.1016/j.tr...
The evolving landscape of brain metastasis: volume II
Brain metastasis (BrM) represents the most common intracranial malignancy, arising in up to 30% of all adult cancer patients and contributing signific…
doi.org
January 21, 2026 at 11:00 AM
📖New article in Trends in Cancer. Volume II of “The evolving landscape of brain metastasis” has been published—a review coordinated by Manuel Valiente, 8 years after Volume I, with contributions from 17 leading figures in the field.
🔗Read full article: doi.org/10.1016/j.tr...
🔗Read full article: doi.org/10.1016/j.tr...
📬 Our last newsletter is out
We closed 2025 with a special edition that highlights the year’s main milestones, the scientific advances driven by the network, and the objectives that will shape RENACER’s work in 2026.
🔗Read it here: mailchi.mp/d89158a1f2f5...
We closed 2025 with a special edition that highlights the year’s main milestones, the scientific advances driven by the network, and the objectives that will shape RENACER’s work in 2026.
🔗Read it here: mailchi.mp/d89158a1f2f5...
January 13, 2026 at 5:03 PM
📬 Our last newsletter is out
We closed 2025 with a special edition that highlights the year’s main milestones, the scientific advances driven by the network, and the objectives that will shape RENACER’s work in 2026.
🔗Read it here: mailchi.mp/d89158a1f2f5...
We closed 2025 with a special edition that highlights the year’s main milestones, the scientific advances driven by the network, and the objectives that will shape RENACER’s work in 2026.
🔗Read it here: mailchi.mp/d89158a1f2f5...
2025 was a year of growth and collaboration for #RENACER, with advances shared at key forums. 💡In 2026, we continue connecting research for patient benefit.
🔗 Read the highlights from our General Assembly:
🔗 Read the highlights from our General Assembly:
RENACER celebró su Asamblea General Anual donde reunión a grandes expertos para compartir los últimos avances y novedades en el tratamiento y conocimiento de la metástasis cerebral - Renacer Brain Met
Un año más, la Red Nacional de Metástasis Cerebral (RENACER) reunió a sus miembros y a otros agentes claves interesados en la metástasis cerebral en la Asamblea General celebrada el pasado viernes,…
renacerbrainmet.org
December 23, 2025 at 3:16 PM
2025 was a year of growth and collaboration for #RENACER, with advances shared at key forums. 💡In 2026, we continue connecting research for patient benefit.
🔗 Read the highlights from our General Assembly:
🔗 Read the highlights from our General Assembly:
Latests talks and seminars from the #RENACER team, sharing new advances in neuro-oncology:
➡️ Manuel Valiente, gave a webinar within PETRAnetwork
➡️ Mª Jesús Artiga, presented RENACER at the 20th Ibero-American Congress of Cancer Patients (GEPAC)
➡️ Manuel Valiente, gave a webinar within PETRAnetwork
➡️ Mª Jesús Artiga, presented RENACER at the 20th Ibero-American Congress of Cancer Patients (GEPAC)
December 17, 2025 at 3:33 PM
Latests talks and seminars from the #RENACER team, sharing new advances in neuro-oncology:
➡️ Manuel Valiente, gave a webinar within PETRAnetwork
➡️ Mª Jesús Artiga, presented RENACER at the 20th Ibero-American Congress of Cancer Patients (GEPAC)
➡️ Manuel Valiente, gave a webinar within PETRAnetwork
➡️ Mª Jesús Artiga, presented RENACER at the 20th Ibero-American Congress of Cancer Patients (GEPAC)
Last October, we held the 5th General Assembly of RENACER, a key meeting that brought together several experts to share progress and strengthen collaboration in #BrainMetastasis.
📰 Read here IM Médico's summary and key insights:
📰 Read here IM Médico's summary and key insights:
La potencia computacional aplicada a la radiómica y a la IA acosan a las metástasis cerebrales
Ahora que resulta imprescindible también conocer la resistencia a la localización de lesiones en el cerebro lanzadas desde la mamá o el pulmón y cómo proceder
www.immedicohospitalario.es
December 10, 2025 at 8:45 AM
Last October, we held the 5th General Assembly of RENACER, a key meeting that brought together several experts to share progress and strengthen collaboration in #BrainMetastasis.
📰 Read here IM Médico's summary and key insights:
📰 Read here IM Médico's summary and key insights:
#RENACER unites 5 multidisciplinary groups across Spain to advance research and improve care in #BrainMetastasis. You can meet them all on our website: renacerbrainmet.org/members-coor...
Members & coordinators - Renacer Brain Met
Members & coordinators RENACER is a network established at national level, with international vision, formed by health institutions, basic/translational laboratories and a biobank. Currently, the…
renacerbrainmet.org
November 24, 2025 at 1:25 PM
#RENACER unites 5 multidisciplinary groups across Spain to advance research and improve care in #BrainMetastasis. You can meet them all on our website: renacerbrainmet.org/members-coor...
High pSTAT3 in reactive astrocytes is linked to higher intracranial recurrence and shorter PFS in triple-negative #BreastCancer #BrainMetastases. STAT3 emerges as a potential prognostic biomarker and therapeutic target.
📖 Read the full article: pubmed.ncbi.nlm.nih.gov/40795951/
📖 Read the full article: pubmed.ncbi.nlm.nih.gov/40795951/
STAT3 expression in brain metastases from breast cancer is correlated with molecular subtype and impacts clinical outcome - PubMed
This study indicates that STAT3 expression prevails in reactive astrocytes surrounding triple-negative BrM in comparison to HER2-positive and luminal BrM, and these findings mirror those observed in…
pubmed.ncbi.nlm.nih.gov
November 13, 2025 at 1:24 PM
High pSTAT3 in reactive astrocytes is linked to higher intracranial recurrence and shorter PFS in triple-negative #BreastCancer #BrainMetastases. STAT3 emerges as a potential prognostic biomarker and therapeutic target.
📖 Read the full article: pubmed.ncbi.nlm.nih.gov/40795951/
📖 Read the full article: pubmed.ncbi.nlm.nih.gov/40795951/
Manuel Valiente shared with the researchers at the CNIO the team studies about the tumour microenvironment to challenge #BrainMetastasis in mice and humans. Understanding these interactions helps turn lab discoveries into patient benefit. #ShareToAdvance
November 5, 2025 at 10:13 AM
Manuel Valiente shared with the researchers at the CNIO the team studies about the tumour microenvironment to challenge #BrainMetastasis in mice and humans. Understanding these interactions helps turn lab discoveries into patient benefit. #ShareToAdvance
🧠 Oct 26 is Spain’s National Day of #AcquiredBrainInjury. At #RENACER we study how brain metastasis affects memory, attention & communication.
Because cancer research is not only about prolonging life, but also preserving what makes it truly livable.
Because cancer research is not only about prolonging life, but also preserving what makes it truly livable.
October 26, 2025 at 9:01 AM
🧠 Oct 26 is Spain’s National Day of #AcquiredBrainInjury. At #RENACER we study how brain metastasis affects memory, attention & communication.
Because cancer research is not only about prolonging life, but also preserving what makes it truly livable.
Because cancer research is not only about prolonging life, but also preserving what makes it truly livable.
Everything is ready for the 5th RENACER General Assembly at the Ramón Areces Foundation! We look forward to welcoming clinicians, researchers, patient representatives, and collaborators to share the latest advances in brain metastases.
October 24, 2025 at 8:13 AM
Everything is ready for the 5th RENACER General Assembly at the Ramón Areces Foundation! We look forward to welcoming clinicians, researchers, patient representatives, and collaborators to share the latest advances in brain metastases.
Radiation necrosis (RN) after stereotactic radiosurgery (SRS) can mimic tumor recurrence.
A new study using computational models shows why RN grows faster & offers a growth metric to distinguish them, improving diagnosis and guiding more precise care👉
A new study using computational models shows why RN grows faster & offers a growth metric to distinguish them, improving diagnosis and guiding more precise care👉
Radiation necrosis after radiation therapy treatment of brain metastases: A computational approach - PubMed
Metastasis is the process through which cancer cells break away from a primary tumor, travel through the blood or lymph system, and form new tumors in distant tissues. One of the preferred sites for…
pubmed.ncbi.nlm.nih.gov
October 16, 2025 at 9:30 AM
Radiation necrosis (RN) after stereotactic radiosurgery (SRS) can mimic tumor recurrence.
A new study using computational models shows why RN grows faster & offers a growth metric to distinguish them, improving diagnosis and guiding more precise care👉
A new study using computational models shows why RN grows faster & offers a growth metric to distinguish them, improving diagnosis and guiding more precise care👉
At #RENACER we thank donors and families: your generosity makes research possible, helps us understand #BrainMetastasis and paves the way for better diagnosis and treatment.
🙏 Thank you for turning your generosity into science and a better future.
#EuropeanDonationDay
🙏 Thank you for turning your generosity into science and a better future.
#EuropeanDonationDay
October 11, 2025 at 8:30 AM
At #RENACER we thank donors and families: your generosity makes research possible, helps us understand #BrainMetastasis and paves the way for better diagnosis and treatment.
🙏 Thank you for turning your generosity into science and a better future.
#EuropeanDonationDay
🙏 Thank you for turning your generosity into science and a better future.
#EuropeanDonationDay
🔬Last September 24th was #WorldCancerResearchDay and we wanted to honor the power of research to transform cancer care.
At #RENACER, we promote research as it is the basis for developing earlier diagnoses, personalising treatments and bringing hope to patients with brain metastases.
At #RENACER, we promote research as it is the basis for developing earlier diagnoses, personalising treatments and bringing hope to patients with brain metastases.
September 29, 2025 at 3:47 PM
🔬Last September 24th was #WorldCancerResearchDay and we wanted to honor the power of research to transform cancer care.
At #RENACER, we promote research as it is the basis for developing earlier diagnoses, personalising treatments and bringing hope to patients with brain metastases.
At #RENACER, we promote research as it is the basis for developing earlier diagnoses, personalising treatments and bringing hope to patients with brain metastases.
🆕 The AEMPS offers a monthly newsletter on oncology regulation. If you are a patient, a professional, or a researcher, stay informed of changes shaping the future of cancer by subscribing here: gob.us4.list-manage.com/subscribe?u=...
AEMPS
AEMPS Email Forms
gob.us4.list-manage.com
September 19, 2025 at 10:02 AM
🆕 The AEMPS offers a monthly newsletter on oncology regulation. If you are a patient, a professional, or a researcher, stay informed of changes shaping the future of cancer by subscribing here: gob.us4.list-manage.com/subscribe?u=...
📋At #RENACER, we know biobanks can transform health care —but only with strong legal frameworks.
A study reviews Spain’s biobank laws, their strengths and limitations, and how to enhance their impact. 📖 Read the full article: doi.org/10.1089/bio....
A study reviews Spain’s biobank laws, their strengths and limitations, and how to enhance their impact. 📖 Read the full article: doi.org/10.1089/bio....
Biobanking Legislation in Spain: Advancing or Undermining Its Ethical Values? | Biopreservation and Biobanking
Biobanks are important resources for improving public health and individual care. Some legal frameworks can be more or less conducive to advancing the potential benefits of biobanks. The purpose of…
doi.org
September 8, 2025 at 8:02 AM
📋At #RENACER, we know biobanks can transform health care —but only with strong legal frameworks.
A study reviews Spain’s biobank laws, their strengths and limitations, and how to enhance their impact. 📖 Read the full article: doi.org/10.1089/bio....
A study reviews Spain’s biobank laws, their strengths and limitations, and how to enhance their impact. 📖 Read the full article: doi.org/10.1089/bio....
🧠 Save the Date!
📅 24 Oct 2025 | 🕥 10:30–15:00
📍 Fundación Ramón Areces, Madrid
Join the 5th RENACER GA to share breakthroughs in #BrainMetastasis. Talks by top experts on CNS mets, lung cancer & more. 🔗 Register: bit.ly/3U4ROA3
#Oncology #RENACER
📅 24 Oct 2025 | 🕥 10:30–15:00
📍 Fundación Ramón Areces, Madrid
Join the 5th RENACER GA to share breakthroughs in #BrainMetastasis. Talks by top experts on CNS mets, lung cancer & more. 🔗 Register: bit.ly/3U4ROA3
#Oncology #RENACER
August 28, 2025 at 9:01 AM
🧠 Save the Date!
📅 24 Oct 2025 | 🕥 10:30–15:00
📍 Fundación Ramón Areces, Madrid
Join the 5th RENACER GA to share breakthroughs in #BrainMetastasis. Talks by top experts on CNS mets, lung cancer & more. 🔗 Register: bit.ly/3U4ROA3
#Oncology #RENACER
📅 24 Oct 2025 | 🕥 10:30–15:00
📍 Fundación Ramón Areces, Madrid
Join the 5th RENACER GA to share breakthroughs in #BrainMetastasis. Talks by top experts on CNS mets, lung cancer & more. 🔗 Register: bit.ly/3U4ROA3
#Oncology #RENACER
🧠 New research reveals why #Immunotherapy often fails in symptomatic #BrainMetastases: some astrocytes block T-cell activity. By combining treatments, this local immunosuppression is no longer observed. A promising step towards personalized treatment! bit.ly/3IvfqLw
August 25, 2025 at 8:01 AM
🧠 New research reveals why #Immunotherapy often fails in symptomatic #BrainMetastases: some astrocytes block T-cell activity. By combining treatments, this local immunosuppression is no longer observed. A promising step towards personalized treatment! bit.ly/3IvfqLw
“Driving research forward isn’t just about starting projects; it’s about supporting them all the way through. In the case of RENACER, this ensures that no tumour is left behind. 🗣️Dr Niebla Priego, a postdoctoral researcher in the Brain Metastasis Group at CNIO.
August 19, 2025 at 7:03 AM
“Driving research forward isn’t just about starting projects; it’s about supporting them all the way through. In the case of RENACER, this ensures that no tumour is left behind. 🗣️Dr Niebla Priego, a postdoctoral researcher in the Brain Metastasis Group at CNIO.
The International Agency for Research on Cancer (WHO) and American Cancer Society have launched the 4th edition of the Cancer Atlas, a free tool with global data on cancer trends, risks & prevention. 🌍📊
🔗 canceratlas.cancer.org
🔗 canceratlas.cancer.org
Cancer Atlas
Exposures to numerous potentially modifiable risk factors for cancer vary substantially across and within countries and are often associated with socioeconomic status.
canceratlas.cancer.org
August 5, 2025 at 9:02 AM
The International Agency for Research on Cancer (WHO) and American Cancer Society have launched the 4th edition of the Cancer Atlas, a free tool with global data on cancer trends, risks & prevention. 🌍📊
🔗 canceratlas.cancer.org
🔗 canceratlas.cancer.org
Dr Manuel Vailente & Dr Benedicto Crespo-Facorro reflect on the brain, cancer, & the need of collaboration. From brain metastasis to science communication, they call for research with real impact. #WorldBrainDay
🔗 Full interview:
🔗 Full interview:
20 años de ciencia transformadora: el legado de los Premios Fundación Banco Sabadell.
Coincidiendo con la edición número 20, la Fundación ha impulsado “Conversaciones con Ciencia”, que otorgan la palabra a algunos de los investigadores galardonados con el premio en las ediciones…
www.elperiodico.com
July 22, 2025 at 8:01 AM
Dr Manuel Vailente & Dr Benedicto Crespo-Facorro reflect on the brain, cancer, & the need of collaboration. From brain metastasis to science communication, they call for research with real impact. #WorldBrainDay
🔗 Full interview:
🔗 Full interview:
🧠 Brain metastases affect up to 30% of cancer patients. Yet key aspects remain poorly understood.
MoLab's new review in Mathematical Biosciences explores how mathematical models can predict tumour growth & treatment response.
🔗 sciencedirect.com/science/arti...
MoLab's new review in Mathematical Biosciences explores how mathematical models can predict tumour growth & treatment response.
🔗 sciencedirect.com/science/arti...
July 14, 2025 at 7:30 AM
🧠 Brain metastases affect up to 30% of cancer patients. Yet key aspects remain poorly understood.
MoLab's new review in Mathematical Biosciences explores how mathematical models can predict tumour growth & treatment response.
🔗 sciencedirect.com/science/arti...
MoLab's new review in Mathematical Biosciences explores how mathematical models can predict tumour growth & treatment response.
🔗 sciencedirect.com/science/arti...
The 5th RENACER General Assembly will connect professionals, researchers & all those interested in brain metastasis to learn about the new advances that are being developed in this field.
📅 Friday, Oct 24th
📍 Ramón Areces Foundation, Madrid
🕥 10:30 - 15:00 h
📅 Friday, Oct 24th
📍 Ramón Areces Foundation, Madrid
🕥 10:30 - 15:00 h
July 9, 2025 at 8:02 AM
The 5th RENACER General Assembly will connect professionals, researchers & all those interested in brain metastasis to learn about the new advances that are being developed in this field.
📅 Friday, Oct 24th
📍 Ramón Areces Foundation, Madrid
🕥 10:30 - 15:00 h
📅 Friday, Oct 24th
📍 Ramón Areces Foundation, Madrid
🕥 10:30 - 15:00 h